Dalton in the News
Dalton Investments has joined the International Corporate Governance Network
Dalton Investments is proud to announce that we have joined the International Corporate Governance Network (ICGN). We believe that ICGN’s goal of advancing high standards of corporate governance and investor stewardship globally is a good fit with the principles of …
read more >
Carlyle Launches Tender Offer to Buy Japan’s Hogy Medical
Carlyle Group has launched a takeover bid for Hogy Medical, a Japanese surgical kit manufacturer, offering ¥6,700 per share in a deal that values the company at about $951 million. Dalton, along with related entities, is Hogy Medical’s largest shareholder, …
read more >
India Is in an IPO Frenzy Again. Wait Until It Cools.
Venkat Pasupuleti, Portfolio Manager for the India strategy at Dalton Investments, was recently quoted in Barron’s, discussing the surge of IPOs in India. Retail investors are currently pouring billions into mutual funds, driving up valuations for newly listed companies. While …
read more >
Dalton Partner Discusses AI “Bubble” Debate at Salesforce Annual Conference
Dalton Investments Partner Owens Huang was featured in Central News Agency (CNA) Taiwan’s coverage of Salesforce’s annual Dreamforce conference in San Francisco, where he commented on ongoing debate surrounding whether AI has entered a “bubble” phase. Mr. Huang argued that …
read more >
Dalton Chief Investment Officer Interviewed by Nikkei Business on Why Poison Pills Do Not Work
Dalton CIO, James B. Rosenwald III, recently interviewed with Nikkei Business, discussing recent announcements by Aska Pharmaceutical and Bunka Shutter to potentially implement a poison pill in order to block shareholder efforts to have each company consider going private. The …
read more >
Dalton Investments Highlighted in “Diligent Market Intelligence: Shareholder Activism in Asia 2025 Report”
In their report “Diligent Market Intelligence: Shareholder Activism in Asia 2025”, Diligent highlights Dalton as one of “Asia’s top activist investors”. When the activity of Dalton Investments and its affiliate company Rising Sun Management (through the closed end fund Nippon …
read more >
Dalton Blasts Japan’s Aska Pharma, Bunka Shutter for Takeover Defenses
Dalton Investments’ response to the anti-takeover measures adopted by Aska Pharma and Bunka Shutter—two companies in which it is a major shareholder—was recently featured in Nikkei Asia. Read the article here.
Enhancing Shareholder Democracy in Japan: A Call for Structural Reforms to Corporate Disclosure and AGM Scheduling
Dalton Investments has sent a letter to the Minister of Economy, Trade and Industry (METI), the Minister of Justice, the Commissioner of Financials Services Agency (FSA), and the heads of the Japan Exchange Group (JPX) urging them to consider structural …
read more >
Dalton CIO Jamie Rosenwald appears on Investor’s Sunday Podcast
Dalton CIO Jamie Rosenwald recently appeared on Investor’s Sunday, which is a regular show on Tokyo’s InterFM. The show is co-hosted by Yuko Ezure and Dalton’s own Masumi Nishida, Partner and Managing Director for Dalton’s Tokyo research office. The show …
read more >
More Shareholders Voicing Proposals to Japanese Firms
NHK published an article and TV report on the record number of Japanese firms receiving shareholder proposals this year. It called out Dalton Investments’ proposals to Fuji Media Holdings and Yakult Honsha as high profile cases. Read the article here